Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05470751 · ClinicalTrials.gov registry record

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

A clinical trial of Multiple Sclerosis and Parkinson Disease, sponsored by ConvaTec.

Completed
Registry status
72
Enrollment target
16
Study locations

NCT05470751 is a study of Multiple Sclerosis and Parkinson Disease that has completed, run by ConvaTec. The registered enrollment target is 72 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (88% lower). The trial reports 16 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05470751, a study of Multiple Sclerosis and Parkinson Disease, has completed, sponsored by ConvaTec.

COMPLETED
Registry status
72 participants
Enrollment target
16
Study locations

Study Summary

Male self catherterisng observational study.

Conditions Studied

Multiple Sclerosis Parkinson Disease Spinal Cord Injuries Lower Urinary Tract Symptoms Bladder Outlet Obstruction Enlarged Prostate With Lower Urinary Tract Symptoms Cauda Equina Syndrome Detrusor Underactivity

Interventions

  • DEVICE Intermittent self-catheterisation

Study Locations (16)

Other

  • Centre Hospitalier Universitaire de Bordeaux | Pellegrin Hospital - Urology Department - Bordeaux
  • Assistance Publique Hopitaux de Paris | Pitie Salpetriere University Hospital - Urology Department - Paris
  • Guy's and St Thomas' Foundation Trust | Guy's Hospital - Transplant, Renal and Urology Research - London
  • King's College Hospital NHS Foundation Trust | King's College Hospital - Renal Research Department - London

Essex

  • Broomfield Hospital - Chelmsford
  • Mid and South Essex NHS Foundation Trust | Southend University Hospital - Research & Development - Southend-on-Sea

New Jersey

  • Kessler Institute for Rehabilitation - West Orange

Pennsylvania

  • Trustees of The University of Pennsylvania | Penn Urology Washington Square - Philadelphia

Cheshire

  • Stockport NHS Foundation Trust | Stepping Hill Hospital - Research and Innovation Department - Stockport

Gwent

  • Aneurin Bevan University Health Board | Royal Gwent Hospital - Clinical Research Centre - Newport

Hampshire

  • Southampton General Hospital - Southampton

Kent

  • Kent and Canterbury Hospital | Renal Research Delivery Team - Canterbury

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2023-02-02
Est. Completion 2024-04-06

Sponsor

ConvaTec

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05470751

The ClinicalTrials.gov registry entry for NCT05470751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (88% lower). The listed sponsor is ConvaTec, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Intermittent self-catheterisation is the first listed.

NCT05470751 reports 16 study locations spanning 12 distinct geographic areas - top geographies include Other, Essex, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05470751 about?

NCT05470751 is a clinical study titled "GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology". Male self catherterisng observational study.

What is the current status of trial NCT05470751?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2023-02-02. Estimated completion is 2024-04-06.

What conditions does trial NCT05470751 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Parkinson Disease, Spinal Cord Injuries, Lower Urinary Tract Symptoms, Bladder Outlet Obstruction.

What interventions are being tested in trial NCT05470751?

The interventions under investigation include: Intermittent self-catheterisation (DEVICE).

Who is sponsoring clinical trial NCT05470751?

This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05470751 being conducted?

This trial has 16 study locations across New Jersey, Pennsylvania, Cheshire, Essex, Gwent. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Parkinson Disease

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.